Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ajanta Pharma Ajanta Pharma Ltd. | BSE 2774.00 48.85 (1.79%) | NSE 2768.90 42.00 (1.54%) | Trade | Add

BSE Live

Dec 31, 16:01

2774.00 48.85 (1.79%)

Volume

AVERAGE VOLUME

5-Day

17,804

10-Day

9,897

30-Day

8,578

1,187

Prev. Close

2725.15
Open Price

2729.75

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 31, 15:54

2768.90 42.00 (1.54%)

Volume

AVERAGE VOLUME

5-Day

291,674

10-Day

182,520

30-Day

104,346

77,063

Prev. Close

2726.90
Open Price

2726.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2768.90 (2)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ajanta Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	17.68	17.67	11.80	11.80	11.80
Total Share Capital	17.68	17.67	11.80	11.80	11.80
Reserves and Surplus	823.41	575.64	381.63	286.23	217.03
Total Reserves and Surplus	823.41	575.64	381.63	286.23	217.03
Total Shareholders Funds	841.09	593.31	393.43	298.03	228.83
Minority Interest	0.00	0.00	0.00	0.00	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	33.25	52.30	73.33	76.09	59.55
Deferred Tax Liabilities [Net]	15.16	22.99	23.65	17.09	10.92
Other Long Term Liabilities	2.50	2.50	2.50	2.50	2.50
Long Term Provisions	4.76	2.83	2.98	4.91	2.66
Total Non-Current Liabilities	55.67	80.62	102.46	100.59	75.64
CURRENT LIABILITIES
Short Term Borrowings	17.90	60.54	51.26	95.27	108.71
Trade Payables	109.06	124.54	131.71	101.32	71.19
Other Current Liabilities	58.33	47.63	19.44	43.15	29.59
Short Term Provisions	64.30	42.71	19.92	10.45	8.21
Total Current Liabilities	249.59	275.42	222.33	250.19	217.70
Total Capital And Liabilities	1,146.35	949.35	718.22	648.81	522.17
ASSETS
NON-CURRENT ASSETS
Tangible Assets	283.78	276.82	262.27	231.85	213.36
Intangible Assets	4.31	2.57	10.29	14.27	0.67
Capital Work-In-Progress	170.20	93.55	12.49	2.51	17.22
Fixed Assets	458.29	372.94	285.05	248.64	231.25
Non-Current Investments	40.04	8.46	8.46	8.47	8.46
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	9.34	39.15	48.61	50.75	33.54
Other Non-Current Assets	5.27	8.75	7.09	1.28	3.32
Total Non-Current Assets	512.94	429.30	349.21	309.14	276.58
CURRENT ASSETS
Current Investments	19.46	55.00	0.00	0.00	0.00
Inventories	159.03	155.40	147.60	167.80	113.12
Trade Receivables	258.76	202.22	150.47	141.00	103.98
Cash And Cash Equivalents	136.76	60.39	46.23	11.47	11.53
Short Term Loans And Advances	50.46	46.42	24.04	18.67	16.93
OtherCurrentAssets	8.94	0.62	0.67	0.73	0.03
Total Current Assets	633.41	520.05	369.01	339.67	245.59
Total Assets	1,146.35	949.35	718.22	648.81	522.17
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	15.93	51.23	83.56	67.27	52.42
BONUS DETAILS
Bonus Equity Share Capital	7.09	7.09	1.23	1.23	1.23
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	45.35	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	8.46	8.46	8.46	8.47	8.46
CURRENT INVESTMENTS
Current Investments Quoted Market Value	19.89	56.98	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00